Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenomics and Medication Development for Methamphetamine Dependence

NCT00833443 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00833443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenomics and Medication Development for Methamphetamine Dependence
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2013
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amphetamine dependence, methamphetamine, methamphetamine dependence, pharmacogenetics, substance abuse